###begin article-title 0
Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development
###end article-title 0
###begin p 1
Conceived and designed the experiments: DSD RSA. Performed the experiments: DSD AAK JK. Analyzed the data: DSD AAK JK RSA. Wrote the paper: DSD JK RSA.
###end p 1
###begin p 2
###xml 627 631 <span type="species:ncbi:10090">mice</span>
Aberrant angiogenesis in the eye is the most common cause of blindness. The current study examined the role of interleukin-10 (IL-10) in ischemia-induced pathological angiogenesis called neovascularization during postnatal development. IL-10 deficiency resulted in significantly reduced pathological retinal angiogenesis. In contrast to the choroicapillaris where IL-10 interferes with macrophage influx, IL-10 did not prevent anti-angiogenic macrophages from migrating to the retina in response to hypoxia. Instead, IL-10 promoted retinal angiogenesis by altering macrophage angiogenic function, as macrophages from wild-type mice demonstrated increased vascular endothelial growth factor (VEGF) and nitric oxide (NO) compared to IL-10 deficient macrophages. IL-10 appears to directly affect macrophage responsiveness to hypoxia, as macrophages responded to hypoxia with increased levels of IL-10 and STAT3 phosphorylation as opposed to IL-10 deficient macrophages. Also, IL-10 deficient macrophages inhibited the proliferation of vascular endothelial cells in response to hypoxia while wild-type macrophages failed to do so. These findings suggest that hypoxia guides macrophage behavior to a pro-angiogenic phenotype via IL-10 activated pathways.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 388 391 388 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Nakao1">[1]</xref>
###xml 393 396 393 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Taylor1">[2]</xref>
###xml 398 401 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Hansson1">[3]</xref>
Angiogenesis is a critical process in maintaining tissue homeostasis during numerous physiological functions, such as wound-healing, reproduction, and embryonic development. However, unbridled angiogenesis can result in fulminant host disease. Abnormal angiogenesis is critical to the pathophysiology of diverse disease processes such as atherosclerotic heart disease and several cancers [1], [2], [3].
###end p 4
###begin p 5
###xml 577 580 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Yoshida1">[4]</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Prasad1">5</xref>
###xml 683 686 683 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Arfken1">[6]</xref>
###xml 995 998 995 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Gariano1">[7]</xref>
###xml 1215 1218 1215 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Adamis1">[8]</xref>
###xml 277 285 <span type="species:ncbi:9606">patients</span>
###xml 569 576 <span type="species:ncbi:9606">infants</span>
###xml 660 668 <span type="species:ncbi:9606">patients</span>
In the eye, this becomes especially important as abnormal angiogenesis (neovascularization) leads to blindness in several disease processes. Intraocular neovascularization, as characterized by abnormal retinal or choroidal angiogenesis, is a major cause of decreased vision in patients with diseases such as proliferative diabetic retinopathy (PDR): the leading cause of blindness in working adults, age-related macular degeneration (AMD): the leading cause of blindness in the elderly, and retinopathy of prematurity (ROP): the leading cause of blindness in premature infants [4], 5. In diabetic retinopathy, retinal neovascularization occurs in up to 20% of patients with diabetes [6]. Current laser ablation treatment for PDR has changed little over the 50 years since its first inception, and is applied only after onset of neovascularization. Although it reduces the risk of severe vision loss, laser photocoagulation reduces peripheral and night vision, and is uncomfortable and expensive [7]. There is recent evidence that the pathobiology of PDR is more complex. Immunological mechanisms, including exudation, upregulation of inflammatory mediators, and immune cell infiltration have been implicated in PDR [8]. Retinopathy of prematurity blinds 50,000 newborn babies annually worldwide. Peripheral retinal ischemia and the cessation of normal retinal vessel growth leads to compensatory angiogenesis, tractional retinal detachment, and blindness. Although diseases resulting in ocular neovascularization differ in many aspects, it is believed that tissue ischemia is the underlying cause leading to compensatory angiogenesis. Tissue ischemia can also result in cellular inflammation, including the infiltration of macrophages to the site of ischemia.
###end p 5
###begin p 6
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Sunderkotter1">[9]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Mantovani1">[11]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Sica1">[12]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Mosser1">[13]</xref>
###xml 1279 1283 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 1285 1289 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
Macrophages carry out a wide variety of biological functions, including participation in neovascularization [9]. Macrophages can exhibit both pro-angiogenic and anti-angiogenic functions. This dual function of macrophages seems to be largely dependent upon the polarization of macrophages. Polarization, in turn, seems to be regulated by the production of cytokines in the resident tissue micro-milieu [10], [11], [12], [13]. Macrophages stimulated in the presence of interferon gamma (IFN-gamma), lipopolysaccharide (LPS), or granulocyte macrophage colony-stimulating factor (GM-CSF) produce high levels IL-12, IL-23, IL-6, and tumor necrosis factor alpha (TNF-alpha), and low levels of IL-10. This "classically-activated" macrophage, or M1 macrophage, displays an anti-angiogenic phenotype, and plays an important role in anti-bacterial and pro-inflammatory functions. Macrophages stimulated in the presence of IL-10, IL-4, or IL-13 produce high levels of IL-10 and low levels of pro-inflammatory cytokines such as IL-6 and TNF-alpha. These "alternatively-activated" macrophages, or M2 macrophages, are pro-angiogenic. Of these cytokines, IL-10 may possess the most significant influence on the polarization of macrophages and their ability to regulate angiogenesis in the eye [10], [14].
###end p 6
###begin p 7
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Canataroglu1">[15]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Esser1">[16]</xref>
###xml 160 163 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 251 254 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 294 297 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 437 440 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 670 678 <span type="species:ncbi:9606">patients</span>
###xml 779 787 <span type="species:ncbi:9606">patients</span>
###xml 849 855 <span type="species:ncbi:10090">murine</span>
###xml 939 946 <span type="species:ncbi:9606">infants</span>
AMD is a disease of the elderly characterized by blindness that is secondary to post-developmental choroidal angiogenesis. Termed choroidal neovascularization (CNV), this aberrant ocular angiogenesis develops in senescent tissues. In a mouse model of CNV, it has been shown that IL-10 promotes CNV by preventing macrophage infiltration into the choroid [14]. As the eye ages, IL-10 gene expression is upregulated, resulting in increased CNV in senescent tissues due to the ability of IL-10 to polarize macrophages towards a pro-angiogenic phenotype [10]. Macrophages also seem to be involved in PDR, as macrophages have been identified in the vitreous humor of diabetic patients [15], and have also been found in epiretinal membranes surgically removed from the eyes of diabetic patients [16]. In this study, we sought to determine if IL-10 affects murine retinal neovascularization during postnatal development, the cause of blindness in infants with ROP.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
IL-10-/- mice demonstrate significantly reduced retinal neovascularization in response to ischemia
###end title 9
###begin p 10
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Smith1">[17]</xref>
###xml 237 240 237 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 988 997 988 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figure 1A</xref>
###xml 1041 1050 1041 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figure 1B</xref>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1269 1278 1269 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figure 1C</xref>
###xml 1551 1554 1542 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1667 1676 1658 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figure 1L</xref>
###xml 1741 1744 1732 1735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1812 1815 1803 1806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1035 1039 <span type="species:ncbi:10090">mice</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 1555 1559 <span type="species:ncbi:10090">mice</span>
###xml 1661 1665 <span type="species:ncbi:10090">mice</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
In order to determine if IL-10 affects developmental angiogenesis in the retina, we utilized the oxygen-induced retinopathy (OIR) model to induce tissue ischemia and compensatory retinal neovascularization [17]. Newborn C57BL/6 and IL-10-/- pups were exposed to 75% oxygen for 5 days, between P7 and P12, and then returned to normal air conditions. The initial exposure to high oxygen levels causes central retinal vascular growth to slow or cease completely, and also causes developed retinal vessels to regress. As the pup then matures in a normoxic environment, the non-vascularized retina becomes increasingly metabolically active. The absence of adequate vascularization leads to tissue ischemia and hypoxia. This results in compensatory retinal neovascularization. To measure retinal neovascularization, P17 animals were perfused with FITC-dextran, eyes were harvested, and retinal flatmounts were made. We found that compared to pups that have never been subjected to high oxygen (Figure 1A), age-matched oxygen-treated C57BL/6 mice (Figure 1B) demonstrated significantly more neovascularization with an abundance of new blood vessel tufts, a central loss of normal retinal blood vessels, and increased retinal vascular tortuosity. Oxygen-treated IL-10-/- mice (Figure 1C), however, demonstrated not only significantly reduced neovascularization, but also increased areas of ischemia and nonperfusion that lacked any vasculature. The total area of retinal vascularization was quantified by Metamorphtrade mark software, and oxygen-treated IL-10-/- mice demonstrated significantly less retinal vascularization compared to normoxic and hyperoxic wild-type mice (Figure 1L). Differences in retinal vasculature between wild-type and IL-10-/- mice occur only following exposure to oxygen, as P17 normoxic IL-10-/- retinas show no vascular differences compared to normoxic wild-type P17 retinas (data not shown).
###end p 10
###begin title 11
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
IL-10-/- mice demonstrate significantly reduced retinal neovascularization in response to ischemia.
###end title 11
###begin p 12
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 47 48 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 384 379 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 473 476 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 737 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1002 1023 991 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1058 1061 1047 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1300 1303 1287 1290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 69 73 <span type="species:ncbi:10090">Mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
###xml 1172 1176 <span type="species:ncbi:10090">mice</span>
###xml 1304 1308 <span type="species:ncbi:10090">mice</span>
###xml 1386 1390 <span type="species:ncbi:10090">mice</span>
C57BL/6 and IL-10-/- were exposed to 75%+/-2% O2 from day P7 to P12. Mice were returned to normoxic conditions for 5 days, and on P17 animals were perfused with FITC-dextran, eyes harvested, and retina flatmounts made. Fluorescent microscopy of perfused retinas of (A) normoxic-treated wild-type mice (n = 5), (B) oxygen-treated wild-type mice (n = 5), and (C) oxygen-treated IL-10-/- mice (n = 4) reveal decreased angiogenesis and increased areas of non-perfusion in IL-10-/- mice. This experiment was repeated 2 additional times with similar results (D-G) H&E staining of ocular tissue sections from C57BL/6 oxygen-treated mice exhibit extensive preretinal neovascular loops (arrows), whereas (H-K) ocular tissue sections from IL-10-/- oxygen-treated mice demonstrate a significant reduction in preretinal neovascular loops. Images were acquired at both 40x (D,F,H,J) and 100x (E,G,I,K). (L) The total area of retinal vascularization was quantified using Metamorphtrade mark software as described in Materials and Methods, and plotted as a bar graph. IL-10-/- mice exposed to oxygen had significantly reduced (**P = 0.0006) retinal vascularization compared to wild-type mice exposed to oxygen. (M) A bar graph represents the mean+/-SD number of neovascular loops of 10 separate sections, with IL-10-/- mice demonstrating reduced neovascular loops (**P = 0.0071) compared to wild-type mice following OIR.
###end p 12
###begin p 13
###xml 471 484 467 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figures 1D&#8211;1G</xref>
###xml 528 531 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 608 621 604 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figures 1H&#8211;1K</xref>
###xml 847 850 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 857 866 853 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g001">Figure 1M</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
In addition to retinal flatmounts, eyes from oxygen-treated mice were harvested for histological examination. Eyes were fixed in formalin and 4-microm sections were made and stained with hematoxylin and eosin. The neovascularization was assessed histologically by counting the number of vascular endothelial cell nuclei vitreal to the inner-limiting membrane. The retinas of oxygen-treated wild-type mice contained multiple neovascular tufts extending into the vitreous (Figures 1D-1G), whereas retinas from oxygen-treated IL-10-/- mice had significantly fewer vascular endothelial cells at these locations (Figures 1H-1K). The neovascularization was quantified by counting and averaging 5 separate sections, revealing a significantly higher quantity of neovascular cell nuclei in the oxygen-treated wild-type mice compared to oxygen-treated IL-10-/- mice (Figure 1M).
###end p 13
###begin title 14
Anti-IL-10 immunotherapy results in significantly reduced retinal neovascularization in response to hypoxia
###end title 14
###begin p 15
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 517 526 513 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g002">Figure 2A</xref>
###xml 679 688 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g002">Figure 2B</xref>
###xml 800 809 796 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g002">Figure 2C</xref>
###xml 952 961 939 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g002">Figure 2D</xref>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 242 248 <span type="species:ncbi:10090">murine</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Since we observed less retinal neovascularization in IL-10-/- mice, we sought to determine if IL-10 may be an ideal therapeutic target for the treatment of aberrant retinal angiogenesis. Therefore, we administered blocking antibodies against murine IL-10 in wild-type mice. Anti-IL-10 or IgG antibodies (150 microg) were injected into wild-type mice immediately before exposure to oxygen (day P7), immediately following exposure to oxygen (day P12), and midway between secondary normoxia exposure (days P14 and P16) (Figure 2A). On day P17 mice were perfused with FITC-dextran and retinal flatmounts were made. Fluorescein angiography revealed that compared to IgG treated mice (Figure 2B), mice treated with anti-IL-10 blocking antibodies developed reduced retinal neovascularization following OIR (Figure 2C). Analysis of retinal flatmounts with Metamorphtrade mark software revealed a statistically significant reduction in retinal vascularization (Figure 2D). This suggests that anti-IL-10 immunotherapy may be an attractive avenue for the treatment of retinopathy of prematurity.
###end p 15
###begin title 16
Anti-IL-10 immunotherapy results in significantly reduced retinal neovascularization in response to ischemia.
###end title 16
###begin p 17
###xml 808 829 795 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 126 129 <span type="species:ncbi:10116">rat</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
(A) The experimental scheme for the treatment of C57BL/6 mice with either rat anti-mouse IL-10 blocking antibodies (n = 4) or rat IgG isotype (n = 6) control antibodies (150 microg) immediately before exposure to oxygen (day P7), immediately after exposure to oxygen (day P12), and 2 timepoints midway through secondary exposure to normoxia (days P14 and P16). On day P17 animals were perfused with FITC-dextran, eyes were harvested, and retinal flatmounts were made. Fluorescent angiography of (B) isotype control treated mice and (C) anti-IL-10 treated mice reveal significantly decreased angiogenesis and increased areas of non-perfusion in anti-IL-10 treated mice following oxygen treatment. (D) The total area of retinal vascularization was quantified using Metamorphtrade mark software as described in Materials and Methods and plotted as a bar graph. Anti-IL-10 treated mice had significantly reduced retinal vascularization (**P = 0.0052) compared to IgG treated mice. This experiment was repeated with similar results.
###end p 17
###begin title 18
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
IL-10 does not alter infiltration of F4/80+ macrophages into ischemic retinas, but leads to significantly increased production of pro-angiogenic NO
###end title 18
###begin p 19
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Yoshida2">[18]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Davies1">[19]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Shen1">[20]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Figure 3A</xref>
###xml 697 698 697 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Davies1">[19]</xref>
###xml 845 846 845 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 907 916 907 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Figure 3B</xref>
###xml 966 969 966 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1019 1020 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Figure 3C</xref>
###xml 1209 1212 1209 1212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1297 1298 1297 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1369 1370 1369 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1471 1488 1471 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Figures 3E and 3F</xref>
###xml 1675 1679 1675 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Davies1">[19]</xref>
###xml 1681 1685 1681 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Shen1">[20]</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 231 237 <span type="species:ncbi:10090">murine</span>
###xml 248 251 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
###xml 1213 1217 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
It has been previously shown that macrophages infiltrate the retinas of mice following OIR [18], [19], [20]. Our laboratory has shown that IL-10 prevents the infiltration of macrophages into the choroidal vasculature of the eye in murine models of CNV [14]. We sought to determine if IL-10 prevents the infiltration of macrophages into a distinct vascular plexus of the eye, the retina, following OIR. We stained FITC-perfused retinal flatmounts with an allophycocyanin (APC)-labeled anti-mouse F4/80 antibody to detect the presence of infiltrating macrophages. Wild-type normoxia retinas had very few F4/80+ cells (Figure 3A), which might not be infiltrating macrophages but rather resident F4/80+ retinal microglia [19]. As expected, retinas from oxygen-treated C57BL/6 mice displayed a significant increase in the number of infiltrating F4/80+ macrophages compared to retinas from normoxic control mice (Figure 3B). Surprisingly, retinas from oxygen-treated IL-10-/- mice did not display an increased number of F4/80+ macrophages compared to retinas from wild-type oxygen-treated mice, as similar numbers of F4/80+ cells are observed (Figure 3C). Therefore, the lack of neovascularization observed in IL-10-/- mice following OIR is not simply due to an increased influx of anti-angiogenic F4/80+ macrophages infiltrating the retina. Interestingly, infiltrating F4/80+ macrophages in both groups of oxygen-treated mice resided along FITC-dextran labeled blood vessels (Figures 3E and 3F), supporting previous work that has observed infiltrating macrophages aligning along neovascular tufts following OIR and suggesting macrophages may modulate vessel growth and regression [19], [20].
###end p 19
###begin title 20
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
F4/80+ macrophages infiltrate ischemic retinas of both C57BL/6 and IL-10-/- mice.
###end title 20
###begin p 21
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 911 914 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
Retinal flatmounts of P17, FITC-dextran perfused C57BL/6 normoxia-treated, C57BL/6 oxygen-treated, and IL-10-/- oxygen-treated retinas were stained with Allophycocyanin (APC) anti-mouse F4/80 antibody. In contrast to the paucity of cells in the (A) normoxic wild-type retina, a significant number of F4/80+ macrophages are observed in the retinas of both (B) C57BL/6 oxygen-treated and (C) IL-10-/- oxygen-treated mice. (D, E, F) Examining both macrophage infiltrate and blood vessels reveals that APC-labeled macrophages reside primarily along FITC-dextran perfused blood vessels. Since IL-10 did not prevent macrophage infiltration into the retina, we examined the genetic profile of retinal macrophages. Using splenic wild-type macrophages as a baseline, retinal macrophages from wild-type mice exhibit significantly (p<0.05) increased expression of the pro-angiogenic gene (G) nitric oxide compared to IL-10-/- retinal macrophages following OIR, suggesting that IL-10 promotes angiogenesis by polarizing macrophages towards a pro-angiogenic phenotype.
###end p 21
###begin p 22
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Mantovani2">[21]</xref>
###xml 344 347 344 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1069 1070 1062 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1201 1210 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Figure 3G</xref>
###xml 1327 1331 1320 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Christopherson1">[22]</xref>
###xml 1333 1337 1326 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-MacMicking1">[23]</xref>
###xml 1433 1437 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Parenti1">[24]</xref>
###xml 1439 1443 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Papapetropoulos1">[25]</xref>
###xml 1463 1467 1456 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Tsurumi1">[26]</xref>
###xml 1668 1672 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Ando1">[27]</xref>
###xml 1905 1909 1898 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Ando1">[27]</xref>
###xml 234 237 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 1734 1739 <span type="species:ncbi:10090">mouse</span>
Since IL-10 did not alter the infiltration of macrophages into the retina following OIR, we hypothesized that IL-10 may be altering the angiogenic phenotype of macrophages in the local tissues, as seen in the senescent choroid during CNV in the eye and in systemic tumors [10], [21]. To determine if retinal macrophages from wild-type and IL-10-/- mice were exhibiting differential angiogenic phenotypes, we examined the gene expression profiles of in vivo derived retinal macrophages following oxygen-induced retinopathy. Retinal macrophages were isolated from retinal tissues by density gradient centrifugation. Following RNA isolation and cDNA preparation, several genes were examined, including IL-12, IL-23, IL-1, TNF-alpha, arginase (Arg1), transforming growth factor beta (TGF-beta) (data not shown) and nitric oxide synthase (NOS2). Of all the genes tested, a significant difference between wild-type and IL-10 deficient retinal macrophages was observed only in NOS2, the gene responsible for macrophage nitric oxide (NO) production. Using splenic C57BL/6 F4/80+ macrophages as a baseline, gene expression of NOS2 was found to be significantly higher in wild-type C57BL/6 retinal macrophages (Figure 3G). NO is involved in multiple host processes such as neurotransmission, vasodilation, host defense, and inflammation [22], [23]. NO is also known to influence neovascularization, and its effect can be either pro-angiogenic [24], [25] or anti-angiogenic [26]. These opposing effects of NO on angiogenesis may be dependent upon the local microenvironment. Of potential interest is previous work that has shown that in the retina, nitric oxide is proangiogenic [27]. In their study, Ando et al. found that in a VEGF transgenic mouse model, deficiency of any of the three isoforms of NO (eNOS, iNOS, and nNOS) resulted in a decrease in subretinal neovascularization at P21 during normal development [27]. This suggests that not only is NO proangiogenic in the retina, but that regulation of VEGF driven angiogenesis involves NO.
###end p 22
###begin title 23
IL-10 and hypoxia skew macrophages toward a pro-angiogenic phenotype
###end title 23
###begin p 24
###xml 311 319 311 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 454 455 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 508 509 508 509 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 535 536 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 1102 1111 1102 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4A</xref>
###xml 1271 1274 1271 1274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1363 1366 1363 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
Within the retinas of mice exposed to oxygen-induced retinopathy, there is local tissue hypoxia leading to compensatory angiogenesis. Since macrophages migrate into the hypoxic environment of the retina, we sought to determine the anti-angiogenic behavior of macrophages in response to hypoxia. We developed an in vitro assay where F4/80+ macrophages were isolated from the spleens of wild-type C57BL/6 and IL-10-/- mice by magnetic bead isolation. F4/80+ cells were exposed to either normoxic (5% CO2, 21% O2) or hypoxic (5% CO2, 4% O2) conditions. Following a 24 hour exposure to such conditions, macrophages were then cocultured with human dermal microvascular endothelial (HMVEC) cells. HMVEC cell proliferation was then assessed by [3H] thymidine incorporation. We have previously demonstrated that the anti-angiogenic properties of mouse macrophages could be assessed by coculture with HMVEC cells [10]. Interestingly, IL-10 deficient macrophages exposed to hypoxic conditions significantly inhibited the proliferation of HMVEC cells, while hypoxic wild-type C57BL/6 macrophages failed to do so (Figure 4A). This inhibition of HMVEC proliferation was not observed in normoxic wild-type C57BL/6 macrophages (neither normoxic nor hypoxic-treated) or in normoxic IL-10-/- macrophages. The addition of recombinant IL-10 protein during hypoxic treatment of IL-10-/- macrophages did not result in the restoration of HMVEC proliferation (data not shown), suggesting that IL-10 may be needed during the development and differentiation of macrophages for a pro-angiogenic phenotype to occur.
###end p 24
###begin title 25
Macrophage responses to hypoxia.
###end title 25
###begin p 26
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1737 1740 1737 1740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1969 1972 1969 1972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2035 2038 2035 2038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 536 542 <span type="species:ncbi:10090">murine</span>
Splenic F4/80+ macrophages from IL-10-/- mice (A) significantly inhibit (*P = 0.0163) the proliferation of HMVECs following exposure to hypoxia compared to hypoxia-treated wild-type macrophages. Splenic F4/80+ macrophages from wild-type mice do not significantly (P>0.05) inhibit HMVEC proliferation compared to untreated HMVECs. This could be due to (B) increased expression of VEGF in wild-type macrophages compared to IL-10-/- macrophages. The IL-10 signaling pathway appears to be activated following exposure to hypoxia. RAW 264.7 murine macrophages (C) do not exhibit increased levels of phosphorylation of STAT3 under normoxic conditions (open histogram) compared to IgG stained cells (shaded histogram). However, (E) exposure to hypoxia (open histogram) results in a significant increase in phosphorylation of STAT3 compared to normoxia-treated cells (shaded histogram). This increase in phosphorylation of STAT3 is at levels similar to (D) RAW 264.7 cells exposed to recombinant IL-10 protein for 10 min (open histogram) versus normoxic cells (shaded histogram). Inset numbers indicate percentage of positive cells above normoxic controls. Phosphorylation of STAT3 protein following hypoxia in RAW 264.7 cells was also confirmed with (F) western blot analysis. Phosphorylation of STAT3 occurred following exposure to both recombinant IL-10 protein for 10 min and a 24 hour exposure to hypoxia. Probing of total STAT3 protein was used as a loading control. These findings in RAW macrophages were also observed in primary macrophages (G). Wild-type macrophages treated with recombinant IL-10 protein for 10 minutes or hypoxia for 24 hours demonstrated increased phosphorylation of STAT3 compared to baseline normoxic levels. IL-10-/- macrophages, however, demonstrated decreased levels of pSTAT3 at baseline normoxic levels compared to wild-type normoxic macrophages, and did not upregulate pSTAT3 in response to hypoxia. STAT3 signaling is still intact in IL-10-/- macrophages, as phosphorylation of STAT3 in increased in IL-10-/- macrophages following stimulation with recombinant IL-10 protein. This increase in STAT3 phosphorylation may be due to the (H) significantly increased (*P = 0.0123) production of IL-10 protein by RAW 264.7 macrophages following exposure to hypoxia compared to normoxia-treated RAW macrophages.
###end p 26
###begin p 27
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Berse1">[28]</xref>
###xml 337 341 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Aiello1">[29]</xref>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 601 610 601 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4B</xref>
###xml 712 720 712 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 829 836 829 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 848 851 848 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1153 1156 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1461 1465 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Naug1">[30]</xref>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1442 1446 <span type="species:ncbi:10090">mice</span>
Vascular endothelial growth factor (VEGF), which increases microvascular permeability and is a specific mitogen for endothelial cells, is a pro-angiogenic factor expressed by macrophages [28]. The importance of VEGF in OIR has been shown previously, as inhibition of VEGF results in a significant reduction of retinal neovascularization [29]. Therefore, we examined VEGF gene expression in C57BL/6 and IL-10-/- macrophages following a 24 hour exposure to normoxia or hypoxia. In both conditions, VEGF gene expression was significantly higher in wild-type macrophages compared to IL-10-/- macrophages (Figure 4B). This may partly explain why C57BL/6 macrophages failed to inhibit the proliferation of HMVEC cells in vitro, and why wild-type macrophages promote the development of retinal and pre-retinal neovascularization in OIR in vivo while IL-10-/- macrophages failed to do so despite infiltrating the retina in numbers equal to wild-type mice. This pattern of VEGF expression is restricted to macrophages, as VEGF in whole retinal tissue from oxygen-treated wild-type mice was not significantly elevated compared to normoxic and oxygen-treated IL-10-/- whole retinal tissue (data not shown). Therefore, the localized expression of VEGF on macrophages may be influencing the development of retinal blood vessels. This correlates with the work of Naug et al, who found VEGF-expressing macrophages associated with vitreal loops in wild-type mice following OIR [30].
###end p 27
###begin p 28
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Hu1">[31]</xref>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 718 727 718 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4C</xref>
###xml 909 918 909 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4D</xref>
###xml 1057 1058 1057 1058 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1176 1185 1176 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4E</xref>
###xml 1427 1436 1427 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4F</xref>
###xml 1852 1861 1852 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4G</xref>
###xml 1869 1872 1869 1872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2101 2104 2101 2104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2167 2170 2167 2170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2237 2246 2237 2246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4G</xref>
###xml 2403 2412 2403 2412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Figure 4H</xref>
###xml 2706 2710 2706 2710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Sumimoto1">[32]</xref>
###xml 437 443 <span type="species:ncbi:10090">murine</span>
We next examined whether hypoxia induced IL-10 signaling in immunocompetent wild-type macrophages. IL-10 protein binds to the IL-10 receptor (IL-10R), resulting in phosphorylation and activation of the signal transducer and activator of transcription 3 (STAT3). STAT3 phosphorylation and activation is essential for all known function of IL-10 [31]. To determine if immunocompetent macrophages were undergoing IL-10 signaling, RAW 264.7 murine macrophages were assessed for phosphorylation of STAT3 by flow cytometry and western blot analysis. RAW macrophages cultured in normoxic conditions (21% O2) did not demonstrate increased staining of phospho-STAT3 antibody compared to isotype control antibody stained cells (Figure 4C). RAW macrophages pulsed with recombinant IL-10 protein (100 ng/ml) for 10 minutes demonstrated a significant increase in phospho-STAT3 staining compared to normoxic treated cells (Figure 4D), confirming that IL-10 signaling in macrophages results in phosphorylation of STAT3. RAW macrophages cultured in hypoxic conditions (4% O2) for 24 hours also demonstrated a significant increase in phospho-STAT3 staining compared to normoxic treated cells (Figure 4E). This suggests that when immunocompetent macrophages infiltrate hypoxic regions such as the retina in OIR, the IL-10 signaling pathway is induced. Flow cytometric analysis of STAT3 phosphorylation was confirmed by western blot examination (Figure 4F). RAW macrophages treated with either recombinant IL-10 protein (100 ng/ml) for 10 minutes or hypoxia for 24 hours demonstrated increased phosphorylation of STAT3. These findings in RAW macrophages were also observed in primary macrophages. Wild-type macrophages treated with IL-10 protein for 10 minutes or hypoxia for 24 hours demonstrated increased phosphorylation of STAT3 compared to baseline normoxic levels (Figure 4G). IL-10-/- macrophages, however, demonstrated decreased levels of pSTAT3 at baseline normoxic levels compared to wild-type normoxic macrophages, and did not upregulate pSTAT3 in response to hypoxia. STAT3 signaling is still intact in IL-10-/- macrophages, as phosphorylation of STAT3 is increased in IL-10-/- macrophages following stimulation with recombinant IL-10 protein (Figure 4G). Interestingly, supernatants from RAW macrophages cultured under hypoxic conditions demonstrate a significant increase in the production of IL-10 protein (Figure 4H). Therefore, phosphorylation of STAT-3 in macrophages following hypoxia may be due to autocrine secretion of IL-10 by macrophages in response to hypoxia and subsequent engagement of the IL-10 receptor. It has been shown that STAT3 activation and signaling can result in the expression of VEGF [32], correlating with our earlier observation of increased VEGF gene expression levels in immunocompetent macrophages.
###end p 28
###begin title 29
Discussion
###end title 29
###begin p 30
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 730 734 730 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 1225 1229 1225 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-White1">[33]</xref>
###xml 1595 1599 1595 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Lewis1">[34]</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
In summary, IL-10 promotes retinal neovascularization in a mouse model of oxygen-induced retinopathy. In contrast to previous reports that analyzed the regulation of choroidal macrophages by IL-10 [14], IL-10 did not prevent the infiltration of macrophages into the retina, but rather polarized the macrophage genetic profile towards a pro-angiogenic phenotype. This difference in IL-10 function may be attributable to the local tissue micro milieu, as the hypoxic drive and regional soluble and membrane-bound signals in diverse vascular beds may differ, i.e. the retinal vasculature versus the choriocapillaris. Although IL-10 promotes angiogenesis by preventing the infiltration of anti-angiogenic macrophages into the choroid [14], this study suggests that in the retina, IL-10 promotes angiogenesis by directly polarizing macrophages towards a pro-angiogenic phenotype. Unlike choroidal neovascularization, hypoxia or ischemia is the prime driver of retinal and pre-retinal neovascularization observed in diabetic retinopathy and ROP. Hypoxia induces a profound change in the phenotype of macrophages. A recent study demonstrated that more than 30 pro-angiogenic genes were upregulated by hypoxia in primary macrophages [33], including VEGF and inducible nitric oxide synthase (iNOS). Most of the work on hypoxia and macrophages has focused on tumor-associated macrophages (TAMs). Macrophages have been shown to accumulate in hypoxic regions of tumors, and secrete multiple growth factors and pro-angiogenic cytokines that promote tumor growth, angiogenesis, metastasis, and immune evasion [34]. To our knowledge, this is the first study that reveals that hypoxia and IL-10 function synergistically to influence macrophage function and angiogenic homeostasis. It is also noteworthy that the pro-angiogenic effects of hypoxic macrophages are IL-10 dependent and require IL-10 mediated signal transduction.
###end p 30
###begin p 31
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Silvestre1">[35]</xref>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 703 709 <span type="species:ncbi:9606">humans</span>
###xml 881 889 <span type="species:ncbi:9606">patients</span>
The diverse and complex regulation of angiogenesis by IL-10 is highlighted by the finding that in a mouse model of post-developmental surgically-induced hindlimb ischemia, IL-10 appears to function in an anti-angiogenic manner, and does so by downregulating VEGF expression [35]. These findings illustrate the multifaceted role of IL-10 in regulating angiogenesis. The vascular bed and the tissue type likely have a profound impact on the ability of IL-10 to regulate macrophage behavior after tissue injury. The success of anti-IL-10 immunotherapy in our studies of mice during OIR was achieved by systemic depletion of IL-10 by intraperitoneal injection. If IL-10 immunotherapy is to be translated to humans as a potential treatment modality for retinopathy, local intraocular injection of anti-IL-10 antibodies or other IL-10 inhibitors, similar to anti-VEGF injections for AMD patients, may be desirable to minimize the systemic effects in non-ocular vascular beds.
###end p 31
###begin p 32
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Jacobs1">[36]</xref>
###xml 597 601 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Sennlaub1">[37]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Fischer1">[38]</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Ando1">[27]</xref>
###xml 1346 1350 1342 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Jung1">[39]</xref>
###xml 1451 1455 1447 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Mechoulam1">[40]</xref>
###xml 935 950 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1433 1437 <span type="species:ncbi:10090">mice</span>
The role of IL-10 in the induction of developmental angiogenesis seems to be a highly choreographed process involving multiple factors. Interestingly, all of the genes that were upregulated in macrophages following oxygen-induced retinopathy were found to be 1) significantly upregulated in C57BL/6 macrophages and not in IL-10 deficient macrophages, 2) proangiogenic, and 3) cross regulative. IL-10 has previously been shown to upregulate NO production in activated macrophages in a dose dependent manner [36]. Also, nitric oxide has previously been reported to be upregulated in hypoxic retinas [37]. Our findings demonstrate that this increase in NOS2 expression in the retina may be attributable to infiltrating retinal macrophages. The relationship between nitric oxide and VEGF is highly complex. In other models of hypoxia-induced angiogenesis, VEGF and NO were responsible for increased vascular permeability [38]. In the eye, transgenic mice with increased expression of VEGF in photoreceptors had decreased subretinal neovascularization when nitric oxide was deleted [27], suggesting that VEGF driven angiogenesis was NO dependent. It has also been shown in other cell types that hypoxia results in STAT3 phosphorylation, which increases cellular levels of hypoxia-inducible factor (HIF-1alpha) which in turn, increases VEGF expression [39]. Additionally, increased STAT3 and pSTAT3 levels have been found in the retina of mice following OIR[40].
###end p 32
###begin p 33
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 266 273 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g004">Fig. 4A</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Kelly1">[10]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 625 628 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 690 693 690 693 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 768 775 768 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003381-g003">Fig. 3G</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Apte1">[14]</xref>
###xml 871 874 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
The role of macrophages in preventing retinal angiogenesis appears to be by inhibiting the proliferation of vascular endothelium. Inhibition of vascular endothelial cell proliferation observed in vitro following co-culture with hypoxia-treated IL-10-/- macrophages (Fig. 4A) may be attributable to multiple factors. Our previous work suggests that IL-10 deficient macrophages tend to skew towards a pro-inflammatory/anti-angiogenic phenotype (M1) following activation, whereas wild-type macrophages have a mixed pro/anti inflammatory phenotype [10], [14]. In this study, hypoxia is the stimulus that activates and skews IL-10-/- macrophages towards an M1 phenotype. These M1 polarized IL-10-/- macrophages likely inhibit HMVEC proliferation due to a deficiency of NO (Fig. 3G), or increased expression of FasL, as shown previously [14]. Under normoxic environments, IL-10-/- macrophages are in an inactive, non-polarized state, and thus do not affect HMVEC proliferation.
###end p 33
###begin p 34
Taken as a whole, inhibition of IL-10 signaling in macrophages may be beneficial in not only preventing aberrant angiogenesis in the eye, but may also be relevant in the prevention of tumor-infiltrating macrophages from becoming pro-angiogenic TAMs that have been implicated in tumor progression and metastasis.
###end p 34
###begin title 35
Materials and Methods
###end title 35
###begin title 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 36
###begin p 37
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 41 35 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Cgn</sup>
###xml 31 41 31 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il10<sup>tm1Cgn</sup></italic>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
C57BL/6 and IL-10-/- (B6.129P2-Il10tm1Cgn/J) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). All work was carried out in accordance with Association for Research in Vision and Ophthalmology (ARVO) guidelines. Comprehensive protocols of animal care and experimental design outlined in this study were approved by the Animal Studies Committee of Washington University.
###end p 37
###begin title 38
Oxygen-induced Retinopathy and Quantification of Neovascularization
###end title 38
###begin p 39
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Smith1">[17]</xref>
###xml 457 458 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1960 1961 1937 1938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">Mice</span>
Oxygen-induced retinopathy was produced in mice by the method described by Smith et al. [17]. On day 7 postpartum (P7), neonatal mice and their nursing mothers were exposed to 75%+/-2% oxygen for 5 days. On day P12, mice were then returned to room air for a period of 5 days. At day P17, mice were anesthetized with 0.66 mg/kg ketamine hydrochloride (Vetalar; Parke-Davis) given i.p. Mice were sacrificed by intracardiac perfusion with 2 ml of 20 mg/ml 2x106 molecular weight FITC-dextran (Sigma-Aldrich, St. Louis, MO) in PBS. Eyes were enucleated, fixed in 4% paraformaldehye for 45 min at 4degreesC, and placed in PBS for 15 min at 4degreesC. A dissecting microscope was used to remove the cornea and lens and gently separate the retina from the underlying choroid and sclera. Microscissors were used to make four radial incisions of the retinal eyecup in order to prepare retinal flat mounts on glass slides. Flat mounts were immersed in Gel/Mount (Biomeda Corp., Foster City, CA) and coverslips were carefully placed. Retinal vascularization was analyzed by fluorescent microscopy (Leica LMD 6000 fluorescent microscope; Wetzlar, Germany). Separate images were taken at 63x magnification, and images were merged using the 'specimen overview' function of the microscope software. The extent of retinal vascularization was then quantified by Metamorphtrade mark Imaging software (Universal Imaging, Sunnyvale, CA). Briefly, the entire retina was outlined to identify the total retinal area of each eye. Then, the color threshold of each image was adjusted to highlight only the FITC-perfused vessels of the inclusively highlighted retina. This allowed the determination of total blood vessel area of each retina and the percentage of each retina that is occupied with blood vessels. Data was reported as total retinal vascular area, and the vascular area for all eyes in a treatment group were averaged and compared individually to controls using Student's t test.
###end p 39
###begin p 40
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Retinal neovascularization was also examined by histology. The eyes of P17 mice (n>/=3 per group) were enucleated, fixed in 10% formalin, and embedded in paraffin. Serial 4-microm-thick sections of the eye were obtained and stained with hematoxylin and eosin. Images were obtained at 40x and 100x magnification. All retinal vascular cell nuclei anterior to the internal-limiting membrane were counted. 10 sections were examined, and the average+/-SD of neovascular cell nuclei per sections was obtained. No vascular cell nuclei anterior to the internal-limiting membrane were observed in normoxic control animals.
###end p 40
###begin title 41
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
In Vivo Anti-IL-10 Antibody Treatment
###end title 41
###begin p 42
###xml 361 365 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003381-Qiao1">[41]</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 71 74 <span type="species:ncbi:10116">Rat</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
Rat anti-mouse IL-10 (JES5.2A5; Genzyme) and isotype control antibody (Rat IgG; Sigma) were administered to wild-type mice by intraperitoneal (i.p.) injection. Antibodies (150 microg) were administered at days P7 (before oxygen exposure), P12 (after oxygen exposure), P14, and P16, following the same timeline used previously for the i.p. injections during OIR [41]. Retinal neovascularization was then evaluated on day P17 as described above.
###end p 42
###begin title 43
Staining of retinal macrophages
###end title 43
###begin p 44
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
Retinas were also examined for infiltration of macrophages. Flat-mounts of FITC-dextran perfused retinas were prepared as described above. Retinas were washed with PBS and blocked with 3% BSA in PBS for 30 min at 37degreesC. Following a subsequent washing with PBS, retinas were stained with 1 microg/ml Allophycocyanin (APC)-conjugated anti-mouse F4/80 antibody (eBioscience, San Diego, CA) for 40 min at 37degreesC. Retinas were washed again with PBS, immersed in Gel/Mount (Biomeda Corp., Foster City, CA), coverslipped, and examined by confocal microscopy.
###end p 44
###begin title 45
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro Hypoxic Treatment of Macrophages
###end title 45
###begin p 46
###xml 54 57 54 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 292 293 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 343 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 350 351 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 370 371 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 377 378 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
Spleens were isolated from wild-type C57BL/6 and IL-10-/- mice. Single-cell suspensions were obtained and stained with 1 microg/ml PE-conjugated anti-mouse F4/80 (eBioscience). PE-labeled cells were isolated by positive selection using magnetic separation (Stemcell Technologies, Inc.). F4/80+ macrophages were then exposed to normoxic (5% CO2, 21% O2) or hypoxic (5% CO2, 4% O2) conditions at 37degreesC for 24 hours. Cells were either immediately lysed for RNA isolation or used in the vascular endothelial cell proliferation assay.
###end p 46
###begin title 47
Vascular endothelial cell proliferation assay
###end title 47
###begin p 48
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 462 463 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 666 667 656 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human dermal microvascular endothelial cells (HMVECs) (Lonza, Walkersville, MD) (5x104) in log phase growth were placed in EGM2V media (Lonza, Walkersville, MD) in 96-well round bottom plates and allowed to adhere for 24 hours at 37degreesC. Normoxic or hypoxic macrophages were then added to HMVECs and allowed to co-culture for an additional 12 hours. Macrophages were removed by repeated and gentle pipetting, and HMVECs were incubated with 40 microCi/ml of [3H] thymidine (TRA61- GE Health Care, Piscataway, NJ) for 12 hours. The tissue culture plate was harvested and read using a Topcount harvester and microplate reader (Packard, Meriden, CT). The amount of [3H] thymidine incorporated into the HMVEC cells is directly proportional to the proliferation of the cells.
###end p 48
###begin title 49
Isolation of Retinal Macrophages
###end title 49
###begin p 50
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Retinas from P17 oxygen-treated mice were isolated from the rest of the eye as described above and placed directly in 1 ml of a 1 microg/ml collagenase (Sigma)/PBS solution. Retinas were then passed through a 18-gauge needle to obtain a single-cell suspension, and then allowed to incubate in collagenase for 30 min at 37degreesC. The collagenase solution was then brought to a total volume of 5 ml, and layered on top of 3 ml of Histopaque-1077 (Sigma) solution. Cells were spun at 2000 RPM for 30 min. During centrifugation, mononuclear cells remain at the PBS-Histopaque interface. Cells were isolated from the interface and immediately lysed for RNA isolation.
###end p 50
###begin title 51
Quantitative Analysis of Gene Expression (Quantitative Real-Time RT-PCR)
###end title 51
###begin p 52
###xml 89 92 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1499 1512 1465 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Total RNA was prepared from retinal macrophages from P17 oxygen-treated C57BL/6 and IL-10-/- mice using the RNeasy mini kit (Qiagen, Valencia, CA). RNA was purified by gDNA eliminator spin columns and subsequent DNase treatment in order to minimize the amount of gDNA cross-contamination. cDNA was prepared using the High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). Relative levels of target gene expression were measured on the 7500 Real-time RT-PCR system (Applied Biosystems). For fluorescence measure and assay preparation, specific FAM-490 based Taqman Gene Expression Assay Mix (Applied Biosystems) for each gene of interest and Taqman Universal Master Mix (Applied Biosystems) were used. Relative Quantification PCR analysis was performed using the ABI 7500 SDS Software. The threshold cycle (Ct) values were measured for our endogenous control (beta-actin) and the genes of interest at the logarithmic phase of amplification. The DeltaCt values for the calibrator (negative baseline control) were calculated as the difference between the Ct value of the endogenous control and the target gene of interest (Ct beta-actin - Ct target). This DeltaCt value for the calibrator was then compared to the DeltaCt value of each of our unknown cDNA samples, the difference of these two values were taken to achieve the DeltaDeltaCt value for each gene (DeltaCt unknown - DeltaCt calibrator). The relative fold expression difference was calculated and graphed using the formula: 2(-DeltaDeltaCt).
###end p 52
###begin p 53
Taqman Gene Expression Assay Mixes used (primer/probe sets) include beta-actin (Mm00607939_s1); TNF-alpha (Mm00443258_m1); IL-6 (Mm00446190_m1); IL-12 (Mm01288989_m1); IL-23 (Mm00518984_m1); IL-10 (Mm00439616_m1); FasL (Mm00438864_m1); IL-1beta (Mm00434228_m1); IFN-gamma (Mm00801778_m1); TGF-beta (Mm03024053_m1); Arg1 (Mm00475988_m1); NOS2 (Mm00440485_m1); and VEGF-alpha (Mm00437304_m1).
###end p 53
###begin p 54
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
For RT-PCR of in vitro treated macrophages, IL-10-/- normoxic macrophages were used as a baseline comparison. For in vivo retinal macrophages, splenic F4/80+ macrophages were used as a baseline comparison.
###end p 54
###begin title 55
Assessment of macrophages for phospho-STAT3 expression
###end title 55
###begin p 56
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 16 <span type="species:ncbi:10090">murine</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 379 385 <span type="species:ncbi:9986">rabbit</span>
###xml 414 420 <span type="species:ncbi:9986">rabbit</span>
###xml 484 488 <span type="species:ncbi:9925">goat</span>
###xml 494 500 <span type="species:ncbi:9986">rabbit</span>
###xml 572 578 <span type="species:ncbi:10090">murine</span>
RAW 264.7 murine macrophages (ATCC; Manassas, VA) or splenic F4/80+ cells from C57BL/6 or IL-10-/- mice were placed in complete RPMI media and incubated either in normoxic (21% oxygen) or hypoxic (4% oxygen) conditions for 24 hours. For flow cytometric analysis, cells were fixed and permeabilized with BD Cytofix/Cytoperm (Becton Dickinson). Cells were then stained with either rabbit IgG (2 microg/ml; Sigma) or rabbit anti-phospho STAT3 (1:500; Sigma), followed by FITC-conjugated goat anti-rabbit antibody (2 microg/ml; Sigma). Macrophages stimulated with recombinant murine IL-10 (100 ng/ml; R&D Systems) for 10 min were used as a positive control for staining. Cells were washed, resuspended in PBS, and analyzed using a FACScan flow cytometer (BD Biosciences). Results were analyzed using CellQuest v.3.1f software (BD Biosciences). For examination of STAT3 phosphorylation by western blot, normoxic and hypoxic macrophages were lysed with Triton X-100 buffer (150 mM NaCl, 20 mM 1% Triton X-100), run on SDS-PAGE (10% NuPAGE gel from Invitrogen, Carlsbad, CA), and transferred onto a nitrocellulose membrane (150 mAmp for 90 min). The membrane was incubated with 5% nonfat dry milk for 1 h and washed three times for 10 min each with TBS-T. The blot was then incubated either with anti-phospho STAT3 (Cell Signaling Tech., Danvers, MA) or anti-STAT3 (Sigma) and then washed with TBS-T three times. The blot was then incubated with the corresponding secondary antibody conjugated with HRP for 1 h, washed three times with TBS-T for 10 min each, and then developed using ECL reagent.
###end p 56
###begin title 57
IL-10 enzyme-linked immunosorbent assay (ELISA)
###end title 57
###begin p 58
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
RAW 264.7 macrophages were incubated in either normoxic or hypoxic conditions as described above. Cell supernatants were then harvested and levels of IL-10 protein in cell supernatants were determined using a mouse IL-10 Quantikine ELISA kit (R&D Systems).
###end p 58
###begin title 59
Statistical analysis
###end title 59
###begin p 60
###xml 64 65 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 165 166 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results are presented as mean+/-standard deviation. A Student's t-test was used to assess the statistical significance of the differences between compared groups. A P-value of <0.05 was considered significant.
###end p 60
###begin title 61
References
###end title 61
###begin article-title 62
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth.
###end article-title 62
###begin article-title 63
Macrophage receptors and immune recognition.
###end article-title 63
###begin article-title 64
Inflammation, atherosclerosis, and coronary artery disease.
###end article-title 64
###begin article-title 65
Intraocular neovascularization.
###end article-title 65
###begin article-title 66
Intravitreal pharmacotherapy: applications in retinal disease.
###end article-title 66
###begin article-title 67
Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes.
###end article-title 67
###begin article-title 68
Retinal angiogenesis in development and disease.
###end article-title 68
###begin article-title 69
Immunological mechanisms in the pathogenesis of diabetic retinopathy.
###end article-title 69
###begin article-title 70
Macrophages and angiogenesis.
###end article-title 70
###begin article-title 71
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice.
###end article-title 71
###begin article-title 72
Macrophage polarization comes of age.
###end article-title 72
###begin article-title 73
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.
###end article-title 73
###begin article-title 74
The many faces of macrophage activation.
###end article-title 74
###begin article-title 75
###xml 44 50 <span type="species:ncbi:10090">murine</span>
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration.
###end article-title 75
###begin article-title 76
Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
###end article-title 76
###begin article-title 77
Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.
###end article-title 77
###begin article-title 78
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Oxygen-induced retinopathy in the mouse.
###end article-title 78
###begin article-title 79
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization.
###end article-title 79
###begin article-title 80
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina.
###end article-title 80
###begin article-title 81
In Vivo Immunostaining Demonstrates Macrophages Associate with Growing and Regressing Vessels.
###end article-title 81
###begin article-title 82
Role of tumor-associated macrophages in tumor progression and invasion.
###end article-title 82
###begin article-title 83
Nitric oxide in excitable tissues: physiological roles and disease.
###end article-title 83
###begin article-title 84
Nitric oxide and macrophage function.
###end article-title 84
###begin article-title 85
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
###end article-title 85
###begin article-title 86
###xml 106 111 <span type="species:ncbi:9606">human</span>
Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
###end article-title 86
###begin article-title 87
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity.
###end article-title 87
###begin article-title 88
Nitric oxide is proangiogenic in the retina and choroid.
###end article-title 88
###begin article-title 89
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.
###end article-title 89
###begin article-title 90
Suppression of Retinal Neovascularization in vivo by Inhibition of Vascular Endothelial Growth Factor (VEGF) Using Soluble VEGF-Receptor Chimeric Proteins.
###end article-title 90
###begin article-title 91
Vitreal macrophages express vascular endothelial growth factor in oxygen-induced retinopathy.
###end article-title 91
###begin article-title 92
Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
###end article-title 92
###begin article-title 93
###xml 74 79 <span type="species:ncbi:9606">human</span>
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.
###end article-title 93
###begin article-title 94
Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis.
###end article-title 94
###begin article-title 95
Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies.
###end article-title 95
###begin article-title 96
###xml 76 80 <span type="species:ncbi:10090">Mice</span>
Antiangiogenic Effect of Interleukin-10 in Ischemia-Induced Angiogenesis in Mice Hindlimb.
###end article-title 96
###begin article-title 97
###xml 118 135 <span type="species:ncbi:5693">Trypanosoma cruzi</span>
IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.
###end article-title 97
###begin article-title 98
Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy.
###end article-title 98
###begin article-title 99
Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.
###end article-title 99
###begin article-title 100
###xml 68 73 <span type="species:ncbi:9606">human</span>
STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.
###end article-title 100
###begin article-title 101
Expression and activation of STAT3 in ischemia-induced retinopathy.
###end article-title 101
###begin article-title 102
Interleukin-18 regulates pathological intraocular neovascularization.
###end article-title 102
###begin p 103
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 103
###begin p 104
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NIH Grant K08EY016139 (R.S.A.), Carl Marshall Reeves and Mildred Almen Reeves Foundation Inc. Award (R.S.A.), RPB Career Development Award (R.S.A.), American Federation for Aging Research Grant (R.S.A.), The Knights Templar Eye Foundation, Inc. (D.S.D.) and the International Retina Research Foundation Alston Callahan Scholar Award (D.S.D)
###end p 104

